China's top health authority has banned the use of a minimally invasive surgical procedure to treat Alzheimer's disease. The ...

Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...

Scientists at UCSF combined advanced brain-network modeling, genetics, and imaging to reveal how tau protein travels through ...

US FDA approves updated label for Eli Lilly's Kisunla with new dosing in early symptomatic Alzheimer's disease: Indianapolis Thursday, July 10, 2025, 14:00 Hrs [IST] Eli Lilly and ...

Dementia remains a leading cause of disability and dependency among older adults, affecting an estimated 55 million people globally, according to the World Health Organization.

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment "We are confident that this ...

Test to be available for clinical and research use as soon as this summer, building on Quest's pioneering blood-based AD-Detect product line for assessing symptomatic ...

The National Health Commission said in a notice released on Tuesday that it has recently learned that some medical ...

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment INDIANAPOLIS, ...

Researchers in China dug into the data and published their findings ... which is more severe memory and thinking problems and includes several conditions. Alzheimer’s disease is one type of dementia.

A person diagnosed with dementia has improved survival outcomes in recent years amid significant progress in dementia ...

Empowering, participatory approaches are needed to improve quality of life and health outcomes for people with dementia, write Emily Ong and colleagues Dementia is the seventh leading cause of death ...